

          1. > 24 hours of intensive care unit admission;

          2. Known Glucose-6-phosphate dehydrogenase (G6PD) deficiency;

          3. Pregnancy;

          4. Known allergy to vitamin C;

          5. Known kidney stones within the past 1 year;

          6. Received any intravenous vitamin C during this hospitalization unless incorporated in
             parenteral nutrition;

          7. Expected death or withdrawal of life-sustaining treatments within 48 hours;

          8. Previously enrolled in this study;

          9. Previously enrolled in a trial with which co-enrolment is not allowed.

        The LOVIT trial has broad eligibility criteria and includes patients with a primary
        diagnosis of sepsis (including sepsis caused by viral pathogens as COVID-19).
      